These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38789992)

  • 1. Efficacy and safety of autologous or allogeneic mesenchymal stromal cells from adult adipose tissue expanded and combined with tricalcium phosphate biomaterial for the surgical treatment of atrophic nonunion of long bones: a phase II clinical trial.
    Orozco Delclós L; Soler Rich R; Arriaza Loureda R; Moreno García A; Gómez Barrena E
    J Transl Med; 2024 May; 22(1):493. PubMed ID: 38789992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.
    Blanco JF; Villarón EM; Pescador D; da Casa C; Gómez V; Redondo AM; López-Villar O; López-Parra M; Muntión S; Sánchez-Guijo F
    Stem Cell Res Ther; 2019 Feb; 10(1):63. PubMed ID: 30795797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial: expanded autologous bone marrow mesenchymal cells combined with allogeneic bone tissue, compared with autologous iliac crest graft in lumbar fusion surgery.
    García de Frutos A; González-Tartière P; Coll Bonet R; Ubierna Garcés MT; Del Arco Churruca A; Rivas García A; Matamalas Adrover A; Saló Bru G; Velazquez JJ; Vila-Canet G; García-Lopez J; Vives J; Codinach M; Rodriguez L; Bagó Granell J; Càceres Palou E
    Spine J; 2020 Dec; 20(12):1899-1910. PubMed ID: 32730985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of non-hypertrophic pseudoarthrosis of long bones with a Tissue Engineered Product loaded with autologous bone marrow-derived Mesenchymal Stromal Cells: Results from a phase IIa, prospective, randomized, parallel, pilot clinical trial comparing to iliac crest autograft.
    Chaverri D; Gallardo-Villares S; Pinto JA; Rodríguez L; Codinach M; García-López J; Querol S; Coll R; Vives J; Granell-Escobar F
    Injury; 2024 Jul; 55(7):111596. PubMed ID: 38797000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Study on the Application of Mesenchymal Stromal Cells Combined with Tricalcium Phosphate Scaffold into Femoral Bone Defects.
    Šponer P; Kučera T; Brtková J; Urban K; Kočí Z; Měřička P; Bezrouk A; Konrádová Š; Filipová A; Filip S
    Cell Transplant; 2018 Oct; 27(10):1459-1468. PubMed ID: 30203687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteogenic protein-1 for long bone nonunion: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(6):1-57. PubMed ID: 23074475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of treating non-unions in tibia, femur and humerus with autologous, expanded, bone marrow-derived mesenchymal stromal cells associated with biphasic calcium phosphate biomaterials in a multicentric, non-comparative trial.
    Gómez-Barrena E; Rosset P; Gebhard F; Hernigou P; Baldini N; Rouard H; Sensebé L; Gonzalo-Daganzo RM; Giordano R; Padilla-Eguiluz N; García-Rey E; Cordero-Ampuero J; Rubio-Suárez JC; Stanovici J; Ehrnthaller C; Huber-Lang M; Flouzat-Lachaniette CH; Chevallier N; Donati DM; Ciapetti G; Fleury S; Fernandez MN; Cabrera JR; Avendaño-Solá C; Montemurro T; Panaitescu C; Veronesi E; Rojewski MT; Lotfi R; Dominici M; Schrezenmeier H; Layrolle P
    Biomaterials; 2019 Mar; 196():100-108. PubMed ID: 29598897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Regeneration Using the Freshly Isolated Autologous Stromal Vascular Fraction of Adipose Tissue in Combination With Calcium Phosphate Ceramics.
    Prins HJ; Schulten EA; Ten Bruggenkate CM; Klein-Nulend J; Helder MN
    Stem Cells Transl Med; 2016 Oct; 5(10):1362-1374. PubMed ID: 27388241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method of treatment for nonunion after fractures using mesenchymal stromal cells loaded on collagen microspheres and incorporated into platelet-rich plasma clots.
    Wittig O; Romano E; González C; Diaz-Solano D; Marquez ME; Tovar P; Aoun R; Cardier JE
    Int Orthop; 2016 May; 40(5):1033-8. PubMed ID: 26980620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.
    Stolk J; Broekman W; Mauad T; Zwaginga JJ; Roelofs H; Fibbe WE; Oostendorp J; Bajema I; Versteegh MI; Taube C; Hiemstra PS
    QJM; 2016 May; 109(5):331-6. PubMed ID: 26819296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonunion fracture healing: Evaluation of effectiveness of demineralized bone matrix and mesenchymal stem cells in a novel sheep bone nonunion model.
    Dozza B; Salamanna F; Baleani M; Giavaresi G; Parrilli A; Zani L; Lucarelli E; Martini L; Fini M; Donati DM
    J Tissue Eng Regen Med; 2018 Sep; 12(9):1972-1985. PubMed ID: 30044550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cytotherapy device for rapid screening, enriching and combining mesenchymal stem cells into a biomaterial for promoting bone regeneration.
    Zhuang Y; Gan Y; Shi D; Zhao J; Tang T; Dai K
    Sci Rep; 2017 Nov; 7(1):15463. PubMed ID: 29133959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
    Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
    Trials; 2019 May; 20(1):263. PubMed ID: 31072380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
    Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
    Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing Autologous Multipotent Mesenchymal Stromal Cells and β-Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial.
    Šponer P; Filip S; Kučera T; Brtková J; Urban K; Palička V; Kočí Z; Syka M; Bezrouk A; Syková E
    Biomed Res Int; 2016; 2016():2076061. PubMed ID: 27144159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep.
    Wheeler DL; Lane JM; Seim HB; Puttlitz CM; Itescu S; Turner AS
    Spine J; 2014 Mar; 14(3):435-44. PubMed ID: 24438940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early efficacy evaluation of mesenchymal stromal cells (MSC) combined to biomaterials to treat long bone non-unions.
    Gómez-Barrena E; Padilla-Eguiluz N; Rosset P; Gebhard F; Hernigou P; Baldini N; Rouard H; Sensebé L; Gonzalo-Daganzo RM; Giordano R; García-Rey E; Cordero-Ampuero J; Rubio-Suárez JC; García-Simón MD; Stanovici J; Ehrnthaller C; Huber-Lang M; Flouzat-Lachaniette CH; Chevallier N; Donati DM; Spazzoli B; Ciapetti G; Fleury S; Fernandez MN; Cabrera JR; Avendaño-Solá C; Montemurro T; Panaitescu C; Veronesi E; Rojewski MT; Lotfi R; Dominici M; Schrezenmeier H; Layrolle P
    Injury; 2020 Apr; 51 Suppl 1():S63-S73. PubMed ID: 32139130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical translation of a mesenchymal stromal cell-based therapy developed in a large animal model and two case studies of the treatment of atrophic pseudoarthrosis.
    Prat S; Gallardo-Villares S; Vives M; Carreño A; Caminal M; Oliver-Vila I; Chaverri D; Blanco M; Codinach M; Huguet P; Ramírez J; Pinto JA; Aguirre M; Coll R; Garcia-López J; Granell-Escobar F; Vives J
    J Tissue Eng Regen Med; 2018 Jan; 12(1):e532-e540. PubMed ID: 27684058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Allogeneic Cell-Based Tissue-Engineered Treatments in a Sheep Osteonecrosis Model.
    López-Fernández A; Barro V; Ortiz-Hernández M; Manzanares MC; Vivas D; Vives J; Vélez R; Ginebra MP; Aguirre M
    Tissue Eng Part A; 2020 Sep; 26(17-18):993-1004. PubMed ID: 32122263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
    Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
    Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.